Home Medical OncologyQuestion

How would you approach first-line treatment in a young patient with VHL with intermediate/poor risk metastatic clear cell RCC?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How, if at all, are you modifying your practice and clinical workflow for patients receiving checkpoint inhibitors with data showing improved outcomes for patients receiving infusions earlier in the day?

Would you continue serial PSMA PET scans after 2 negative scans for patients with a persistently rising PSA post-RT?

When considering cytoreductive nephrectomy in metastatic kidney cancer, in which situations would you consider nephron-sparing approaches such as partial nephrectomy or SBRT?

Would you consider utilizing pembrolizumab/enfortumab as a bladder preservation approach in patients with MIBC?

In patients with muscle-invasive bladder cancer, in what clinical scenarios would you consider neoadjuvant cisplatin-based therapy in light of emerging data on enfortumab vedotin plus pembrolizumab?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.